13/11/2026
Planning a major upgrade to your track-and-trace platform?
That may also be the right time to ask a bigger question: should you upgrade what you already have, or evaluate whether switching makes better business sense?
The answer should go beyond software licensing. Infrastructure, support, validation, integrations, operations, scalability, and future upgrade costs can significantly change the 5-year Total Cost of Ownership.
Our latest article looks at when pharma companies should consider switching, what to evaluate, and why modern cloud-native architecture can change the business case.
We also introduce the nTrack Switch Calculator to help organizations compare the potential cost of staying versus switching.
Read the full article: https://buff.ly/Timy1t0
Want to evaluate your current track-and-trace environment and potential 5-year savings?
Start here: https://buff.ly/92aYydH